References
- Ebeling P R., Peterson J M., Riggs B L. Utility of type I procollagen propeptide assays for assessing abnormalities in metabolic bone diseases. J Bone Miner Res 1992; 7: 1243–50
- Eriksen E F., Brixen K, Charles P. New markers of bone metabolism: clinical use in metabolic bone disease. Eur J Endocrinol 1995; 132: 251–63
- Jensen L T., Henriksen J H., Olesen H P., Risteli J, Lorenzen I. Lymphatic clearance of synovial fluid in conscious pigs: the aminoterminal propeptide of type III procollagen. Eur J Clin Invest 1993; 23: 778–84
- Jukkola A, Risteli L, Melkko J, Risteli J. Procollagen synthesis and extracellular matrix deposition in MG-63 osteosarcoma cells. J Bone Min Res 1993; 8: 651–7
- Linkhart S G., Linkhart T A., Taylor A K., Wergedal J E., Bettica P, Baylink D J. Synthetic peptide-based immunoassay for amino-terminal propeptide of type I procollagen: application for evaluation of bone formation. Clin Chem 1993; 39: 2254–8
- Melkko J, Hellevik T, Risteli L, Risteli J, Smedsrød B. Clearance of NH2-terminal propeptides of types I and III procollagen is a physiological function of the scavenger receptor in liver endothelial cells. J Exp Med 1994; 179: 405–12
- Melkko J, Niemi S, Risteli L, Risteli J. Radioimmunoassay of the carboxyterminal propeptide of human type I procollagen. Clin Chem 1990; 36: 1328–32
- Price K M., Silman R, Armstrong P, Grudzinskas J G. Development of a radioimmunoassay for fetal antigen 2. Clin Chim Acta 1994; 224: 95–102
- Prockop D J., Kivirikko K I., Tuderman L, Guzman N A. The biosynthesis of collagen and its disorders. New Engl J Med 1979; 301: 13–23, 77–85
- Pucci-Minafra I, Luparello C, Andriolo M, Basirico L, Aquino A, Minafra S. A new form of tumor and fetal collagen that binds laminin. Biochemistry 1993; 32: 7421–7
- Risteli L, Risteli J. Biochemical markers of bone metabolism. Ann Med 1993; 25: 385–93
- Risteli J, Risteli L. Analysing connective tissue metabolites in human serum. Biochemical, physiological and methodological aspects. J Hepatol 1995; 22(Suppl 2)77–81
- Smedsrød B, Melkko J, Risteli L, Risteli J. Circulating carboxyterminal propeptide of type I procollagen is cleared mainly via the mannose receptor in liver endothelial cells. Biochem J 1990; 271: 345–50
- Sorva A, Tähtelä R, Risteli J, Risteli L, Laitinen K, Juntunen-Backman K, Sorva R. Familial high serum concentrations of the carboxyl-terminal propeptide of type I procollagen. Clin Chem 1994; 40: 1591–3
- Stein G S., Lian J B., Owen T A. Relationship of cell growth to the regulation of tissue-specific gene expression during osteoblast differentiation. FASEB J 1990; 4: 3111–23
- Taubman M B., Goldberg B, Sherr C J. Radioimmunoassay for human procollagen. Science 1974; 186: 1115–7
- Teisner B, Rasmussen H B., Højrup P, Yde-Andersen E, Skjødt K. Fetal antigen 2: an amniotic protein identified as the aminopropeptide of the α1(I) chain of human procollagen type I. APMIS 1992; 100: 1106–14
- Trivedi P, Risteli J, Risteli L, Hindmarsh P C., Brook C G D, Mowat A P. Serum concentrations of the type I and III procollagen propeptides as biochemical markers of growth velocity in healthy infants and children and in children with growth disorders. Pediatr Res 1991; 30: 276–80